Erandi Lira‐Navarrete

Biochemistry, Genetics and Molecular BiologyChemistryImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation”.

Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation

Glycobiology(2020)10.1093/glycob/cwaa036

N/A

0.561DataRank · unranked

41 citations

Matilde de las Rivas, Erandi Lira‐Navarrete, Ana García-García, Ramón Hurtado‐Guerrero, Henrik Clausen +2 more

Identification of global inhibitors of cellular glycosylation

Nature Communications(2023)10.1038/s41467-023-36598-7

N/A

0DataRank · unranked

31 citations

Christian Büll, Thomas D. Madsen, Erandi Lira‐Navarrete, Thomas Mandel Clausen, Alex E. Clark +17 more

Rational Design of Dual-Domain Binding Inhibitors for N-Acetylgalactosamine Transferase 2 with Improved Selectivity over the T1 and T3 Isoforms

JACS Au(2024)10.1021/jacsau.4c00633

N/A

0DataRank · unranked

6 citations

Collin J. Ballard, Erandi Lira‐Navarrete, Tanausú Santos, Serena Monaco, Juan C. Muñoz–García +11 more